trial
as of 2026-07-01Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
NCTId NCT00160147
at a glance
Phase 3 · Terminated
Enrollment 60 (actual)
Sponsored by Solvay Pharmaceuticals
Primary completion 2008-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Terminated
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2005-12
Primary completion
2008-01
Eligibility
ALL · 65 Years · 90 Years
Interventions & indications
Sponsors
Solvay PharmaceuticalsLead Sponsor
Investigators
1
Global Clinical Director SolvayStudy Director
Sites
51 total
Phoenix, United StatesCarson, United StatesLong Beach, United StatesPasadena, United StatesSan Marino, United StatesSanta Ana, United StatesHamden, United StatesNew Britain, United StatesNorwalk, United StatesMiami, United StatesNorth Miami, United StatesOrange City, United States
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
60
Phase
PHASE3
Primary Completion Date
2008-01
Status
TERMINATED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator